Compare Suncor Energy Inc. (SU) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Suncor Energy Inc. vs GeneDx Holdings Corp — how do they compare? Suncor Energy Inc. trades at $71.22 (market cap $82.76B), while GeneDx Holdings Corp trades at $69.42 (market cap $2.02B). The key difference: Suncor Energy Inc. is far larger — about 41× GeneDx Holdings Corp's market cap, and Suncor Energy Inc. pays a 2.39% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Suncor Energy Inc. for 57 Days and GeneDx Holdings Corp for 19 Days on average.
| SU | WGS | |
|---|---|---|
Market Cap | $82.76B | $2.02B |
Volume | 3,832,959 | 734,640 |
Sector | Energy | Health |
52-Week High | $71.87 | $167.51 |
52-Week Low | $38.17 | $34.51 |
Typical Hold Time | 57 Days | 19 Days |
Enterprise Value | $89.29B | $2.05B |
Dividend Yield | 2.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Suncor Energy (SU) trades at $68.14, down slightly by 0.12% on the day. The stock exhibits a bullish technical trend, supported by strong fundamentals including a P/E of 13.46 and a net income margin of 14.7%. Recent Q2 2026 earnings beat expectations, and the company announced a $0.60 dividend for H2-2026. Analyst consensus is strongly positive with 23 buy ratings and no sell recommendations. News highlights include asset divestments and a planned CEO transition to Peter Zebedee in 2027.
The outlook for SU is favorable, driven by robust cash flow, aggressive shareholder returns via buybacks and dividends, and a discounted valuation relative to peers. Key risks include commodity price volatility, operational disruptions from weather events, and execution of the leadership transition. The stock's current price near recent highs suggests momentum, but investors should weigh these factors against the strong fundamental backdrop.
GeneDx Holdings Corp. (WGS) trades at $68.53, down 4.18% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company reported a net loss of $21.02 million for 2025, though Q2 2026 earnings beat expectations. Revenue growth is positive, but profitability remains a challenge with negative margins. Analyst consensus is strongly bullish with a $81.00 price target, supported by recent product launches and institutional interest.
The outlook hinges on execution toward profitability amid high cash burn. Investment opportunity lies in the genomic testing market expansion and analyst optimism, but risks include sustained losses, competitive pressure, and reliance on financing. The stock's trajectory will depend on achieving projected margin improvements and revenue scalability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
